Peter Hiatt

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

Margaret Rosenfeld, Claire Wainwright, Mark Higgins et al. · The Lancet Respiratory Medicine · 2018 · 270 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +14

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial

Félix Ratjen, Stephanie D. Davis, Sanja Stanojevic et al. · The Lancet Respiratory Medicine · 2019 · 115 citations

Pharmacy, Child Health, Pediatrics +11

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

Janet A. Englund, Pedro A. Piedra, Young‐Min Ahn et al. · The Journal of Pediatrics · 1994 · 89 citations

Pharmacy, Infectious Diseases, Pediatrics +16

Bronchodilator Responsiveness in Infants and Young Children with Cystic Fibrosis

Peter Hiatt, Howard Eigen, Pui Tak Yu et al. · American Review of Respiratory Disease · 1988 · 76 citations

Medicine, Pediatrics, Pharmacology +16

Infants with cystic fibrosis: Pulmonary function at diagnosis

Robert S. Tepper, Peter Hiatt, Howard Eigen et al. · Pediatric Pulmonology · 1988 · 63 citations

Medicine, Child Health, Pediatrics +17